Showing 20 of 64 recruiting trials for “angiocentric-glioma”
Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type
RecruitingNCT06883214 ↗
Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Platelets Activation in Brain Neoplasms
RecruitingNCT05489783 ↗
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
👨⚕️ Anna Piotrowski, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Jul 2022View details ↗
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
👨⚕️ Stefano Luminari, MD, Ematologia, AUSL IRCCS Reggio Emilia📍 2 sites📅 Started Feb 2022View details ↗
RecruitingNCT05859659 ↗
Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)
The Use of Focused Ultrasound and DCE K-trans Imaging to Evaluate Permeability of the Blood-Brain Barrier
Study of GC101 TIL in Brain Glioma (Soochow2)
👨⚕️ Qing Lan, Second Affiliated Hospital of Soochow University📍 1 site📅 Started May 2021View details ↗
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RecruitingNCT04975139 ↗
Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks
👨⚕️ Jiayi Huang, M.D., Washington University School of Medicine📍 1 site📅 Started Sep 2020View details ↗
A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)
MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
Developing Fast Pediatric Imaging
👨⚕️ Kawin Setsompop, PhD, Boston Children Hospital/ Massachusetts General Hospital📍 3 sites📅 Started Apr 2019View details ↗
Non-invasive Glioma Characterization Through Molecular Imaging
Seizure Treatment in Glioma
Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
👨⚕️ Alison Moskowitz, MD, Memorial Sloan Kettering Cancer Center📍 10 sites📅 Started Nov 2016View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →